Telehealth this Fall: DEA Rules, FDA Guidance, and AI’s Growing Impact on Health Care
CCHP’s October Newsletter is here! This month’s topics include – Awaiting DEA Telemedicine Rules as Studies Highlight Telehealth’s Role in Treating Opioid Use Disorder; FDA Releases Final Guidance on Decentralized Clinical Trials, Highlighting Telehealth Components; NIHCM Highlights the Role of AI in Transforming Health Care; Latest Policy Developments in CCHP’s Telehealth Policy Finder and Policy Trends Map; HHS Provides Telehealth Resources for Substance Use Disorder and Behavioral Health.